1. Experimental Evaluation of a Cell Module for Hybrid Liver Support
- Author
-
Gerlach, J.C., Botsch, M., Kardassis, D., Lemmens, P., Schön, M., Janke, J., Puhl, G., Unger, J., Kraemer, M., Busse, B., Böhmer, C., Belal, R., Ingenlath, M., Kosan, M., Kosan, B., Sültmann, J., Patzold, A., Tietze, S., Rossaint, R., Müller, C., Mönch, E., Sauer, I.M., and Neuhaus, P.
- Abstract
Aim of the study was to evaluate a hybrid liver support system in a porcine model of acute liver failure, after hepatectomy. Pigs with a body weight of 70±18 kg underwent total hepatectomy and porto - cavo - caval shunting as well as ligation of the bile duct and the hepatic artery. Control animals were connected to the system (including capillary membrane plasma separation) containing a four compartment bioreactor with integral oxygenation and decentralized mass exchange but without liver cells. The treatment group received hybrid liver support with the same system including 370±42 g primary isolated porcine parenchymal liver cells in co-culture with hepatocyte nursing cells, tissue engineered to liver- like structures at high density. Treatment started after complete recovery from anesthesia and was performed continuously. A positive influence on peripheral vascular resistance and a reduced need of catecholamine dosage was observed in the treatment group. Hybrid liver support with a cell module upscaled for clinical application significantly prolonged survival time in animals after hepatectomy with the longest survival being 26 hours in the control group an 57 hours in the treatment group.
- Published
- 2001
- Full Text
- View/download PDF